All Publications

Data provided by UCSF Profiles, powered by CTSI at UCSF
  1. Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R, Members of the Nonalcoholic Steatohepatitis Clinical Research Network. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Aliment Pharmacol Ther. 2022 Mar 17. View in PubMed
  2. Rinella ME, Satapathy SK, Brandman D, Smith C, Elwir S, Xia J, Gibson M, Figueredo C, Angirekula M, Vanatta JM, Sarwar R, Jiang Y, Gregory D, Agostini T, Ko J, Podila P, Gallo G, Watt KD, Siddiqui MS. Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium. Clin Gastroenterol Hepatol. 2022 Feb 18. View in PubMed
  3. Brandman D. Jaundice in Polycystic Liver Disease: More Than Meets the Eye. Clin Liver Dis (Hoboken). 2021 Mar; 17(3):165-168. View in PubMed
  4. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant. 2021 09; 21(9):3148-3156. View in PubMed
  5. Danielle Brandman. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clinics in Liver Disease. 2021 Feb 1; 25(1):1-18. View in PubMed
  6. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion. Transpl Infect Dis. 2021 Jun; 23(3):e13563. View in PubMed
  7. Xu CQ, Zhou K, Brandman D. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2021 03 01; 181(3):310-312. View in PubMed
  8. Brandman D. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clin Liver Dis. 2021 02; 25(1):1-18. View in PubMed
  9. Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. View in PubMed
  10. Brandman D. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? Clin Liver Dis (Hoboken). 2019 Jun; 13(6):158-161. View in PubMed
  11. Adler E, Brandman D. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. JAMA Intern Med. 2019 Jul 01. View in PubMed
  12. Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. Prog Transplant. 2019 09; 29(3):213-219. View in PubMed
  13. Brandman D, Terrault NA. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality. Hepatobiliary Surg Nutr. 2019 Jun; 8(3):277-279. View in PubMed
  14. Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonascia J, Chalasani N, Neuschwander-Tetri B, Sanyal AJ, NASH Clinical Research Network. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Clin Gastroenterol Hepatol. 2019 08; 17(9):1877-1885.e5. View in PubMed
  15. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ, NASH Clinical Research Network. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 01; 17(1):156-163.e2. View in PubMed
  16. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 04; 67(4):1628-1630. View in PubMed
  17. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N, NASH Clinical Research Network. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018 01; 67(1):134-144. View in PubMed
  18. Kardashian AA, Dodge JL, Roberts J, Brandman D. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. Liver Int. 2018 03; 38(3):553-563. View in PubMed
  19. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022. View in PubMed
  20. Dakson A, Brandman D, Thibault-Halman G, Christie SD. Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study. Spinal Cord. 2017 Nov; 55(11):1033-1038. View in PubMed
  21. Brandman D. Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Aliment Pharmacol Ther. 2017 05; 45(9):1272-1273. View in PubMed
  22. D. Brandman, M. Boyle, S. McPherson, M. Van Natta, A. Sanyal, K. Kowdley, B. Tetri, N. Chalassani, M. Abdelmalek, N.A. Terrault, A. McCullough, R. Bettencourt, C. Caussy, D. Kleiner, C. Behling, E. Doo, J. Tonascia, Q. Anstee, R. Loomba. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. . 2017 Jan 1; 66(1):s69-s70. View in PubMed
  23. D. Brandman, M. Boyle, S. McPherson, M. Van Natta, A. Sanyal, K. Kowdley, B. Tetri, N. Chalassani, M. Abdelmalek, N.A. Terrault, A. McCullough, R. Bettencourt, C. Caussy, D. Kleiner, C. Behling, E. Doo, J. Tonascia, Q. Anstee, R. Loomba. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. Journal of Hepatology. 2017 Jan 1; 66(1):s69-s70. View in PubMed
  24. S. Epstein, D. Brandman, J. Dodge, J. Roberts, N. Terrault. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. Transplantation Journal. 2014 Jul 1; 98:740. View in PubMed
  25. L. Zeng, D. Brandman, J. Roberts, N. Terrault. Early Post-Operative Outcomes in Liver Transplantation for Nonalcoholic Steatohepatitis: A Retrospective Analysis. Transplantation Journal. 2014 Jul 1; 98:740. View in PubMed
  26. L. Zeng, D. Brandman, J. Roberts, N. Terrault. Early Post-Operative Outcomes in Liver Transplantation for Nonalcoholic Steatohepatitis: A Retrospective Analysis. . 2014 Jul 1; 98:740. View in PubMed
  27. S. Epstein, D. Brandman, J. Dodge, J. Roberts, N. Terrault. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. . 2014 Jul 1; 98:740. View in PubMed
  28. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. View in PubMed
  29. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. View in PubMed
  30. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. View in PubMed
  31. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 2002 Aug 05; 111(1):11-20. View in PubMed